SCHEMBL4440625

SCHEMBL4440625

C=CCN([C]=O)C(N)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11881489 0.80
SCHEMBL4933350 0.79
SCHEMBL4087556 0.77 ALDH1A1 (0.35)
SCHEMBL6922595 0.77 ALDH1A1 (0.45)
SCHEMBL27949 0.76 ALDH1A1 (0.39)
SCHEMBL4952774 0.71 SMN1; SMN2 (0.39)
SCHEMBL3652188 0.70 ALDH1A1 (0.52)
SCHEMBL17209104 0.70 ALDH1A1 (0.41)
SCHEMBL569861 0.70 ALDH1A1 (0.52)
SCHEMBL4243340 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1852422-A2 Nitrosated and nitorsylated alpha-andrenergic receptor antagonist compounds, compositions and their uses Nitromed, Inc. (US) 2007-11-07 EP claimed
US-20020173659-A1 Indole derivatives for the treatment of osteoporosis SMITH KLINE BEECHAM SPA 2002-11-21 US claimed
US-6184237-B1 Substituted pyridine compounds and methods of use AMGEN INC. 2001-02-06 US claimed
US-6037345-A Method for inhibiting neoplastic cells and related conditions by exposure to quinazolinedione and pyridopyrimidinedione derivatives CELL PATHWAYS, INC. (US) 2000-03-14 US claimed
US-4880810-A Quinazolinediones and pyridopyrimidinediones PFIZER INC. (US) 1989-11-14 US claimed
US-4234580-A INSECTICIDES; MITACIDES UNION CARBIDE CORPORATION (US) 1980-11-18 US claimed
CN-108064173-B Partial insulin receptor agonists 默沙东公司 2021-05-18 CN disclosed
US-20140200209-A1 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY VIIV HEALTHCARE COMPANY (US) 2014-07-17 US disclosed
WO-2013103687-A2 TREATMENT OF HEART FAILURE AND SUDDEN CARDIAC DEATH RHODE ISLAND HOSPITAL (US) 2013-07-11 WO disclosed
US-20130172559-A1 POLYCYCLIC CARBAMOYLPYRIDONE DERIVATIVE HAVING HIV INTEGRASE INHIBITORY ACTIVITY VIIV HEALTHCARE COMPANY (US) 2013-07-04 US disclosed
US-20090312349-A1 ANTI-INFLAMMATORY MEDICAMENTS DECIPHERA PHARMACEUTICALS, LLC 2009-12-17 US disclosed
US-20060247217-A1 Tricyclic protein kinase inhibitors BERGER DAN M 2006-11-02 US disclosed
US-20050070558-A1 6-Phenyldihydropyrrolopyrimidinedione derivatives ALMIRALL PRODESFARMA S.A. (ES) 2005-03-31 US disclosed
WO-2004076434-A1 DIPEPTIDYL PEPTIDASE INHIBITORS AIC (BE) 2004-09-10 WO disclosed
US-6114390-A AN ARGININAMIDE OR ORNITHINAMIDE COMPOUND AS TREATING MEMORY LOSS, MIGRAINE, SLEEP DISORDERS, PAIN, CARDIOVASCULAR DISEASES, SUBARACHNOIDAL BLEEDING, VASCULAR-HYPERTROPHIC CHANGES, CEREBRAL AND CORONARY VASOSPASMS KARL THOMAE GMBH (DE) 2000-09-05 US disclosed
US-4818247-A COLORFASTNESS CIBA-GEIGY CORPORATION (US) 1989-04-04 US disclosed
US-4234580-A INSECTICIDES; MITACIDES UNION CARBIDE CORPORATION (US) 1980-11-18 US disclosed
US-3931268-A Methylhydrazinomethyl-substituted benzoic acid amides HOFFMANN-LA ROCHE INC. (US) 1976-01-06 US disclosed